EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Pegavision (6491) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of Pegavision TWD 448, price TWD 402, upside +11.5%, quality 52 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · TW · ISIN TW0006491004

P Broad data Sep 23, 2026

Pegavision

6491 · TW

UndervaluedQuality growthThe stock appears undervalued with acceptable quality.

Fair value 448.25 TWD · Undervalued (+12%)
!Quality 52/100
!Expensive Growth (revenue 5y +12.1 %/yr)
Highly profitable · 22.0% net margin (TTM)
Low debt · generates free cash flow
Ranks above peers (11/14)
Wide moat 73/100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

496.50 TWD 45.87 TWD Fair Value 448.25 TWD Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range 45.87 TWD – 496.50 TWD · fair‑value band 300.11 TWD – 723.74 TWD · the 402.00 TWD price screens below the 448.25 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.

Follow Pegavision in your weekly email

Every Wednesday you see whether Pegavision is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Pegavision Corporation manufactures and sells medical devices, and optical and precision instruments in Taiwan. It offers soft contact lenses. The company was founded in 2009 and is based in Taoyuan City, Taiwan. Pegavision Corporation operates as a subsidiary of Pegatron Corporation.

Stock analysis

Pegavision (6491) currently trades at 402.00 TWD, while our model-based Fair Value estimate is 448.25 TWD, implying the stock looks roughly 10.3% undervalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 522.76 TWD per share, and 13 of the 26 models we run sit above the 402.00 TWD price.

Bear case: the Asset-Based group reads lowest at 101.47 TWD, and 13 of the 26 models stay below the price. Evidence for this calculation is high.

Scenario range: 300.11 TWD (bear) to 723.74 TWD (bull), the price of 402.00 TWD sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 52/100 (solid quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Pegavision reported revenue of 7.0B TWD in FY2025 versus 5.6B TWD in FY2021, a compound +5.9%/yr. Reported net income was 1.6B TWD in FY2025, compounding +6.9%/yr from FY2021.

Key figures

Market cap 31.7B TWD (≈ $997M) · P/E ratio 19.5 · P/S ratio 4.50 · EPS (TTM) 20.64 TWD · Dividend yield 3.3% · Net margin 23.1% · Return on equity 14.9% · Return on assets (EBIT) 15.1%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).

What moves the price

The share trades about 1% below its 52-week high and 46% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −12% fair-value upside, at 12%, 6491 screens cheaper than that median.

Fair Value models

Bear 300.11 TWD Fair Value 448.25 TWD Bull 723.74 TWD
Model Each model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (15.10 TWD per share) are deliberately not added. Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence Evidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF 239.23 TWD 424.88 TWD 899.06 TWD 75
Growth DCF 232.65 TWD 460.34 TWD 824.11 TWD 75
EPV 194.74 TWD 224.47 TWD 250.49 TWD 74
All 26 models by family
DCF Models
FCF DCF 239.23 TWD 424.88 TWD 899.06 TWD 75
Owner Earnings 199.24 TWD 394.64 TWD 774.45 TWD 72
5Y Revenue Exit 220.96 TWD 408.75 TWD 678.37 TWD 70
5Y EBITDA Exit 319.31 TWD 628.86 TWD 1,045 TWD 73
5Y P/E Exit 317.23 TWD 624.20 TWD 1,003 TWD 68
10Y Revenue Exit 218.17 TWD 405.58 TWD 725.89 TWD 64
10Y EBITDA Exit 292.98 TWD 574.80 TWD 1,059 TWD 65
10Y P/E Exit 291.55 TWD 571.22 TWD 1,021 TWD 61
Earnings-Based
Graham-Dodd 144.15 TWD 863.92 TWD 1,204 TWD 63
Lynch FV 246.18 TWD 351.68 TWD 457.19 TWD 61
PEG = 1.0 246.18 TWD 351.68 TWD 457.19 TWD 57
EPV 194.74 TWD 224.47 TWD 250.49 TWD 74
Dividend Discount
Gordon GGM 102.58 TWD 213.28 TWD 338.35 TWD 66
DDM Multi-Stage 102.58 TWD 179.84 TWD 223.85 TWD 66
Multiples
P/E Multiple 349.78 TWD 466.37 TWD 582.96 TWD 63
P/S Multiple 240.60 TWD 320.81 TWD 401.01 TWD 58
P/B Multiple 270.28 TWD 360.37 TWD 450.47 TWD 55
EV/EBIT 316.31 TWD 416.31 TWD 516.30 TWD 66
EV/EBITDA 369.21 TWD 486.83 TWD 604.46 TWD 67
EV/Revenue 208.82 TWD 291.31 TWD 373.80 TWD 54
Asset-Based
NCAV (Graham) 75.72 TWD 101.47 TWD 151.45 TWD 54
Growth DCF
Growth DCF 232.65 TWD 460.34 TWD 824.11 TWD 75
Rev-Margin DCF 220.96 TWD 400.47 TWD 653.44 TWD 71
Economic Profit
Residual Income 147.80 TWD 183.85 TWD 405.78 TWD 70
ROIC Compounder 221.93 TWD 317.41 TWD 408.95 TWD 71
Growth Earnings
Growth-Adj P/E 365.93 TWD 522.76 TWD 679.58 TWD 67

Open the full fair value analysis →

Notify me when 6491 reaches fair value

Put 6491 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 52/100

Of which business quality 54 · Market factors (momentum, volatility) 75

Profitability 56
Margins and returns on capital today
Quality Growth 22
Are margins and returns improving?
Cashflow 65
Earnings quality: real cash, not paper profit
Fin. Strength 86
Balance sheet, leverage, solvency risk
Investment 1
Disciplined investing over empire-building
Low Volatility 70
Calm price path (market factor)
Momentum 75
Price trend over the last 3–12 months (market factor)
52W Momentum 80
Distance to the 52-week high (market factor)
Net Issuance 63
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality Growth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+3.3%
Revenue growth 3 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.7%
Revenue growth 5 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.1%
Start year 2020 (pandemic). Over 10 years: +18.3% a year
Revenue growth 13 years Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+30.1%
What shareholders gained per year (last 5 years), in TWD What the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+18.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year+15.5%
Dividend (yield on the price)3.3%
Pace: 5 vs 10 years Two data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.16% vs 26%, slowing
Profit margin 2020 to 2025 Operating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.21% → 26%
Start year 2020 (pandemic)

Growth Forecast

A lot of optimism in the price
The price assumes about as much growth as the company has delivered so far and more than analysts expect.
What the price assumes This turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+13.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect Analysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+8.9%
Yearly sales growth analysts expect, extended to five years.
After inflation (Taiwan: IMF forecast 1.6% a year to 2030, 1.5% from 2016 to 2025) that is about +11.2% a year for the price and +7.2% for the forecasts.
Forecast 2026 (sales)+14.8%
Forecast 2027 (sales)+8.7%
Projected 2028 (sales)+7.8%
Projected 2029 (sales)+7.0%
Projected 2030 (sales)+6.2%

Watch 6491, get fair value alerts →

Compare Pegavision with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 204 stocks

Beats the industry median on 11/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 52 · Below median
Fair Value upside +10% · Above median
Profitability
Return on equity (TTM) 15% · Top 25%
Return on assets 8% · Top 25%
Net margin (TTM) 22% · Top 25%
Operating margin (TTM) 29% · Top 25%
Growth and dividend
Revenue growth 18% · Top 25%
Dividend yield (TTM) 3.3% · Above median
Balance sheet
Debt / equity 0.04× · Below median

Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper

P/E (TTM) 19.5× · Cheaper than median
P/B 2.77× · Pricier than median
P/S (TTM) 4.39× · Pricier than median
P/FCF 0.9× · Cheapest 25%
EV/EBITDA 11.6× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)49 · sector 19
FUTURE (revenue growth)92 · sector 28
PAST (return on equity)59 · sector 25
HEALTH (low debt)98 · sector 96
DIVIDEND (yield)66 · sector 33

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Intuitive Surgical, Inc ISRG $402.09 $353.38 −12%
EssilorLuxottica Société anonyme EL €144.50 €158.95 +10%
Medline Inc MDLN $34.43 $30.15 −12%
Becton, Dickinson and Company BDX $183.00 $103.53 −43%
Alcon Inc ALC $65.59 $39.78 −39%
ResMed Inc RMD A$31.61 A$34.77 +10%
West Pharmaceutical Services, Inc WST $371.09 $137.28 −63%
Sartorius Stedim Biotech S.A DIM €206.40 €54.82 −73%
Straumann Holding STMN CHF 97.86 CHF 45.50 −54%
Solventum Corporation SOLV $88.75 $130.51 +47%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Pegavision Fair Value". https://www.fairvalue-calculator.com/stock/6491

Frequently asked questions

Is Pegavision (6491) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of 448.25 TWD versus a price of 402.00 TWD, about +12% upside (undervalued).
What is the fair value of 6491?
Our model-based fair value for Pegavision is 448.25 TWD (as of Sep 23, 2026), built from audited fundamentals. The current price: 402.00 TWD.
What is the quality score of 6491?
Pegavision has a Quality Score of 52/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Pegavision (6491)?
Our model-based price target is the fair value of 448.25 TWD (as of Sep 23, 2026) from 26 valuation models. Cautious scenario 300.11 TWD, optimistic scenario 723.74 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Pegavision stock forecast for 2026?
Our models put fair value at 448.25 TWD, about +12% upside versus a price of 402.00 TWD (undervalued). Cautious scenario 300.11 TWD, optimistic scenario 723.74 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Pegavision (6491)?
Pegavision reported trailing-twelve-month revenue of about 7.3B TWD (latest available figure, as of Sep 23, 2026).
Does Pegavision pay a dividend?
Pegavision currently shows a dividend yield of about 3.31% relative to its recent price (as of Sep 23, 2026).
What growth is priced into Pegavision (6491)?
For today's price to be fair in a discounted-cash-flow model, Pegavision would have to grow free cash flow by +13.0 % per year for five years (discount rate 9.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +12.1 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of 6491 use?
Our models discount Pegavision at 9.5 %: a base by market capitalisation (large), damped by beta 0.89, country premium for Taiwan. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Pegavision that is +13.0 % per year a year over ten years, using the same discount rate (9.5 %) and the same formula as our fair value.
How much growth has Pegavision (6491) delivered so far?
Over the past 5 years revenue at Pegavision grew +12.1 % a year. The price currently implies +13.0 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Pegavision (6491) growing?
The median revenue growth in the sector is +4.2 % a year. That is the yardstick for the growth priced into Pegavision (+13.0 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Pegavision (6491)?
The free-cash-flow yield on the price is 3.60 %: that much free cash flow Pegavision produces per unit of market value. When it exceeds the discount rate of our models (9.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Pegavision (6491)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Pegavision it is 448.25 TWD per share (as of Sep 23, 2026), against a price of 402.00 TWD. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Pegavision stock overvalued or undervalued in 2026?
As of Sep 23, 2026, 6491 trades below its calculated fair value: price 402.00 TWD, fair value 448.25 TWD, a gap of about +12% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 6491?
No. The price is what the market pays today (402.00 TWD); the fair value is what the company's own numbers justify (448.25 TWD). For Pegavision the two are 46.25 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Pegavision worth?
The market values Pegavision at about 31.7B TWD (market capitalisation, as of Sep 23, 2026). Per share that is 402.00 TWD; our models calculate a fair value of 448.25 TWD per share.
What do the bullish and bearish scenarios say about 6491?
Our models span a range for Pegavision: cautious scenario 300.11 TWD, base 448.25 TWD, optimistic 723.74 TWD per share (as of Sep 23, 2026, price 402.00 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 6491?
Pegavision trades at a price-to-earnings ratio of 19.5 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 448.25 TWD is built from several models across several years. Other multiples: P/B 2.8, P/S 4.4, EV/EBITDA 11.6.
How solid is the balance sheet of Pegavision (6491)?
Balance-sheet figures for Pegavision (as of Sep 23, 2026): return on equity 14.9%, debt of 0.04 per unit of equity. They feed the Quality Score of 52/100, which measures business quality independently of the share price.
How far is 6491 from its 52-week high?
Pegavision trades at 402.00 TWD, about 1% below its 52-week high of 407.50 TWD and 46% above the low of 274.50 TWD (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 448.25 TWD is for.
Which stocks are comparable to Pegavision?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Medline Inc, Becton, Dickinson and Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Pegavision stock attractive at the current price?
The data as of Sep 23, 2026: price 402.00 TWD, calculated fair value 448.25 TWD (+12%), Quality Score 52/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 6491 calculated?
We run Pegavision through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 448.25 TWD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Pegavision currently trades 12 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Pegavision (6491)?
The closing price on Sep 24, 2026 was 402.00 TWD. Our model-based fair value is 448.25 TWD, about +12% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Pegavision right now?
A fairly wide model range (300.11 TWD to 723.74 TWD) leaves room in how you read the outcome. The price sits in the lower half of our model range, the side with the larger margin of safety. The data supports the verdict: every model runs on fully documented inputs.
Where does the earnings growth of Pegavision (6491) come from?
Earnings per share at Pegavision grew +29.4 % a year from 2014 to 2025. Broken into its drivers: revenue per share +16.8 %, EBIT margin +9.9 %, tax rate +0.2 %, residual (interest, one-offs) +0.6 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Pegavision

How large is the market capitalisation of Pegavision (6491)?
The market capitalisation of Pegavision is 31.7B TWD (≈ $997M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Pegavision (6491)?
The price-to-sales ratio of Pegavision is 4.50 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Pegavision (6491)?
Earnings per share at Pegavision are 20.64 TWD (price ÷ EPS = P/E 19.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Pegavision (6491)?
The dividend yield of Pegavision is 3.3% (payout 64.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Pegavision (6491)?
The net margin of Pegavision is 23.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Pegavision (6491)?
The return on equity (ROE) of Pegavision is 14.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Pegavision (6491)?
On an EBIT basis the return on assets of Pegavision is 15.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Pegavision (6491)?
The operating margin of Pegavision is 28.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Pegavision (6491)?
Revenue at Pegavision is growing +18.3% versus a year earlier (3y avg +3.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Pegavision (6491)?
Earnings per share at Pegavision are growing −3.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Pegavision (6491) hold?
Pegavision holds more cash than debt, 470M TWD net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Pegavision in the live analysis

One click puts Pegavision on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.